Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Masimo Corporation
  6. Summary
    MASI   US5747951003

MASIMO CORPORATION

(MASI)
  Report
Delayed Nasdaq  -  04:00 2022-12-05 pm EST
142.55 USD   -2.03%
12/05Needham Adjusts Masimo's Price Target to $173 From $149, Keeps Buy Rating
MT
12/01Masimo Corp : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
11/30Transcript : Masimo Corporation Presents at Piper Sandler 34th Annual Healthcare Conference, Nov-30-2022 08:30 AM
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/29/2022 11/30/2022 12/01/2022 12/02/2022 12/05/2022 Date
140.65(c) 144.94(c) 145.74(c) 145.5(c) 142.55(c) Last
275 838 703 716 619 744 299 024 495 786 Volume
-0.92% +3.05% +0.55% -0.16% -2.03% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 2 021 M - -
Net income 2022 136 M - -
Net Debt 2022 - - -
P/E ratio 2022 53,0x
Yield 2022 -
Sales 2023 2 362 M - -
Net income 2023 191 M - -
Net Debt 2023 - - -
P/E ratio 2023 39,9x
Yield 2023 -
Capitalization 7 648 M 7 648 M -
Capi. / Sales 2022 3,78x
Capi. / Sales 2023 3,24x
Nbr of Employees 2 200
Free-Float 66,8%
More Financials
Company
Masimo Corporation is a global medical technology company that develops, manufactures and markets a variety of noninvasive monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. Its patient monitoring solutions incorporates a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The Company provides its... 
More about the company
Ratings of Masimo Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about MASIMO CORPORATION
12/05Needham Adjusts Masimo's Price Target to $173 From $149, Keeps Buy Rating
MT
12/01Masimo Corp : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial S..
AQ
11/30Transcript : Masimo Corporation Presents at Piper Sandler 34th Annual Healthc..
CI
11/30New Prospective Study Finds That Masimo SpHb« Noninvasive and Continuous Hemoglobin Mon..
BU
11/22Masimo to Present in Piper Sandler 34th Annual Healthcare Conference
BU
11/22Peer-Reviewed Study Finds That Masimo SET Pulse Oximetry Has No Clinically Significant ..
AQ
11/21Peer-Reviewed Study Finds That Masimo SET« Pulse Oximetry Has No Clinically Significant..
BU
11/21Peer-Reviewed Study Finds That Masimo Set« Pulse Oximetry Has No Clinically Significant..
CI
11/18Law firm Sidley warns clients about rules that may hinder activists
RE
11/17Masimo Shares Higher as Court Rules Former Executive Guilty of Stealing Trade Secrets
MT
11/17Federal Court Rules for Masimo in Suit Against Former Engineer for Unlawful Theft of Co..
BU
11/16Insider Buy: Masimo
MT
11/16Insider Buy: Masimo
MT
11/15Transcript : Masimo Corporation Presents at Stifel 2022 Healthcare Conference..
CI
11/09Masimo to Present in Stifel 2022 Healthcare Conference
BU
More news
News in other languages on MASIMO CORPORATION
11/30Neuer prospektiver Studie zufolge kann die nichtinvasive und kontinuierliche Hämoglobin..
11/30Selon une nouvelle étude prospective, la solution de surveillance continue et non invas..
11/30Un nuevo estudio prospectivo revela que la monitorización continua no invasiva de la he..
11/21Une étude évaluée par des pairs révèle que l'oxymètre de pouls Masimo Set« ne présente ..
11/17Les actions de Masimo augmentent après que le tribunal ait déclaré l'ancien cadre coupa..
More news
Analyst Recommendations on MASIMO CORPORATION
More recommendations
ETFs positioned on MASIMO CORPORATIONETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Global X Telemedicine & Digital Health ETF - USD5.76%7.23%-NC
Global X Telemedicine & Digital Health Dist - GBP5.75%8.08%-NC
Global X Telemedicine & Digital Health - USD5.75%9.59%-NC
BMO Equal Weight US Health Care Index ETF - CAD1.48%3.09%United_States
BMO Equal Weight U.S. Health Care Hedged to...1.45%3.30%United_States
More ETFs positioned on MASIMO CORPORATION
Chart MASIMO CORPORATION
Duration : Period :
Masimo Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MASIMO CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 142,55 $
Average target price 159,67 $
Spread / Average Target 12,0%
EPS Revisions
Managers and Directors
Joe E. Kiani Chairman & Chief Executive Officer
Micah Young Chief Financial Officer & Executive Vice President
Yongsam Lee Chief Information Officer & Executive VP
Anand Sampath Executive VP-Operations & Clinical Research
Jon Curtis Coleman President-Worldwide Sales & Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
MASIMO CORPORATION-50.30%7 648
SHOCKWAVE MEDICAL, INC.40.13%9 032
NOVOCURE LIMITED3.89%8 400
PENUMBRA, INC.-26.21%8 008
GETINGE AB-36.57%6 574
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.-4.97%5 226